Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06374277 · ClinicalTrials.gov registry record · NA
Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence
A NA study of Depression and Hypertension, sponsored by University of Tennessee.
- Recruiting
- Registry status
- NA
- Development phase
- 388
- Enrollment target
- 2
- Study locations
NCT06374277: Recruiting NA study of Depression and Hypertension, sponsored by University of Tennessee.
NCT06374277 is a NA study of Depression and Hypertension that is actively recruiting participants, run by University of Tennessee. The registered enrollment target is 388 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (51% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06374277, a NA study of Depression and Hypertension, is actively recruiting participants, sponsored by University of Tennessee.
- RECRUITING
- Registry status
- NA
- Development phase
- 388 participants
- Enrollment target
- 2
- Study locations
Study Summary
Socioeconomically disadvantaged populations with multiple chronic conditions have high rates of nonadherence to essential chronic disease medications after hospital discharge. Medication nonadherence after hospital discharge is significantly associated with increased mortality and higher rates of readmissions and costs among these patients. Major patient-reported barriers to essential medication use after hospital discharge among low-income individuals are related to social determinants of health (SDOH) and include: 1) financial barriers , 2) transportation barriers, and 3) system-level barriers. Although, medication therapy management services are important during care transitions, these services have not proven effective in improving medication adherence after hospital discharge, highlighting a critical need for innovative interventions. The Medication Affordability, Accessibility, and Availability in Care Transitions (Med AAAction) Study will test the effectiveness of a pharmacy-led care transitions intervention versus usual care through a pragmatic randomized controlled trial of 388 Medicaid and uninsured hospital in-patients with MCC from three large healthcare systems in Tennessee. The intervention will involve: 1) medications with zero copay, 2) bedside delivery then home delivery of medications, and 3) care coordination provided by certified pharmacy technicians/health coaches to assist with medication access, medication reconciliation, and rapid and ongoing primary care follow-up. We will examine the impact of the intervention during 12 months on 1) medication adherence (primary outcome) and 2) rapid primary care follow-up, 30-day readmissions, hospitalizations and emergency department visits, and costs. We will conduct key informant interviews to understand patient experience with the acre received during and after care transitions. By examining effectiveness of the intervention on outcomes including medication adherence, health care utilization, costs, an
Primary Outcome
Adherence to oral chronic disease medications will be assessed for the groups every 3 months using the pill count method (primary method). Additionally, we will measure patient self-reported adherence to chronic disease medications at 3-month, 6-month, and 12-month follow-up by using the following question "On how many of the last seven days, did you take your recommended medication" for each of their chronic disease medications (secondary method).
Conditions Studied
Interventions
- OTHER Med AAAction intervention
Study Locations (2)
Tennessee
- University of Tennessee Medical Center - Knoxville
- University of Tennessee Health Science Center/Regional One Health - Memphis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 388 participants |
| Start Date | 2024-04-06 |
| Est. Completion | 2028-01-31 |
| Phase | NA |
What NCT06374277 shows while recruiting
NCT06374277 is an interventional study that assigns participants to a tested intervention. The registered 388 participants enrollment target is mid-sized for trials with a published cap, below the 786-participant average among 679 other Depression trials with a reported enrollment target (51% lower).
The record links to 10 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which Med AAAction intervention is the first listed.
NCT06374277 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT06374277 about?
NCT06374277 is a clinical study titled "Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence". Socioeconomically disadvantaged populations with multiple chronic conditions have high rates of nonadherence to essential chronic disease medications after hospital discharge. Medication nonadherence after hospital discharge is significantly associated with increased mortality and higher rates of re...
What is the current status of trial NCT06374277?
This trial is currently recruiting. It is a NA study. The enrollment target is 388 participants. The study started on 2024-04-06. Estimated completion is 2028-01-31.
What conditions does trial NCT06374277 study?
This clinical trial studies the following conditions: Depression, Hypertension, Stroke, Diabetes, Coronary Artery Disease.
What interventions are being tested in trial NCT06374277?
The interventions under investigation include: Med AAAction intervention (OTHER).
Who is sponsoring clinical trial NCT06374277?
This trial is sponsored by University of Tennessee, which has 96 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06374277 being conducted?
This trial has 2 study locations across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06374277's enrollment target sits among peer trials
388 113th of 679 higher than 567 of 679 other Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
Cold and Heat Investigation to Lower Levels of Depression
RECRUITING · NA
-
Dosing rTMS for Depression Post-SCI
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Brief Interventions for Coping with Distress
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04092010 · 388 participants · NA
Improving Preschool Outcomes by Addressing Maternal Depression in Head Start
- NCT05157880 · 388 participants · NA
Building Resiliency in Dyads of Patients With an ANI Admitted to the Neuro-ICU and Their Informal Caregivers
- NCT05748613 · 388 participants · NA
Anxiety Sensitivity Treatment to Reduce Anxiety in Alzheimer's
- NCT07018726 · 388 participants · NA
Addressing Emotional Distress in Dyads of Persons With a Young Onset Dementia (YOD) and Their Care-partners
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy